Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...

Tofacitinib etocomil ointment 1.0% has proven effective in treating mild-to-moderate atopic dermatitis, achieving significant ...

Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It ...

Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

Read on to learn more about the types and symptoms of dermatitis. This article also looks at causes, treatment options, and more. Atopic dermatitis, or eczema, can run in families, and usually ...

Within the atopic dermatitis (AD) field, Sanofi has been developing the IRAK4 degrader SAR444656 (KT-474) in collaboration ...

Learning Objectives: - Understand the various causes of canine allergic and atopic dermatitis. - Gain insight into using available treatment options to manage canine allergic and atopic dermatitis. - ...

From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

Our skin works tirelessly to protect us, yet when it faces a condition, it can feel frustrating and overwhelming. Skin issues ...